RET proto-oncogene
FactorWikipedia
9
MENTIONS
2
EPISODES
2
PODCASTS
Search complete. 9 mentions across 2 episodes found for "RET proto-oncogene".
Sep 25, 2026
Benjamin P. LevyGUEST
Why do you need to do RNA? Well, we know that there are several fusions that we need to identify.
Benjamin P. LevyGUEST
ALK, RET, ROS, NTRK, NRG.
Benjamin P. LevyGUEST
These are fusions that are optimally detected and unearthed through RNA.
Benjamin P. LevyGUEST
And so when you're doing these, you've got to make sure that you're sending your tissue off for both DNA and RNA.
Benjamin P. LevyGUEST
These drugs that have landed front and center in the advanced stage setting have moved up.
Benjamin P. LevyGUEST
in early stage.
Benjamin P. LevyGUEST
We've got data like the ADORA, data like ALINA, data from the RET adjuvant study that was presented at ASCO.
Benjamin P. LevyGUEST
We need to do this in early stage as well.
Melina MarmarelisGUEST
So meaning that it is not specific to the origin, the, you of that cancer, but rather the genetic change that the drug is targeting.
Melina MarmarelisGUEST
So an example of this as lung cancer is the RET targeted therapies, R-E-T.
Melina MarmarelisGUEST
These were approved across cancers, in particular in thyroid cancers.
Melina MarmarelisGUEST
and in lung cancer.